癌症预防标志物的发展轨迹。
Development tracks for cancer prevention markers.
作者信息
Baker Stuart G, Kramer Barnett S, Prorok Philip C
机构信息
Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892-7354, USA.
出版信息
Dis Markers. 2004;20(2):97-102. doi: 10.1155/2004/309391.
Abstract
We provide a general framework for describing various roles for biomarkers in cancer prevention research (early detection, surrogate endpoint, and cohort identification for primary prevention) and the phases in their evaluation.
摘要
我们提供了一个通用框架，用于描述生物标志物在癌症预防研究中的各种作用（早期检测、替代终点以及一级预防的队列识别）及其评估阶段。
相似文献
1
Development tracks for cancer prevention markers.癌症预防标志物的发展轨迹。
Dis Markers. 2004;20(2):97-102. doi: 10.1155/2004/309391.
2
Biomarkers as surrogates for cancer development.作为癌症发展替代指标的生物标志物。
Curr Oncol Rep. 2000 May;2(3):242-50. doi: 10.1007/s11912-000-0074-0.
3
American Association for Cancer Research 98th Annual Meeting.美国癌症研究协会第98届年会。
IDrugs. 2007 Jun;10(6):353-5.
4
Prevention of oncological diseases: primary and secondary prevention.肿瘤疾病的预防：一级预防和二级预防。
Int J Biol Markers. 2012 Dec 27;27(4):e337-43. doi: 10.5301/JBM.2012.10370.
5
[Cancer screening - useful but not so easy].
Dtsch Med Wochenschr. 2015 Sep;140(19):1424. doi: 10.1055/s-0041-106027. Epub 2015 Sep 24.
6
Biomarkers as intermediate end points in chemoprevention trials.
J Natl Cancer Inst. 1990 Apr 4;82(7):555-60. doi: 10.1093/jnci/82.7.555.
7
Biomarker research with prospective study designs for the early detection of cancer.采用前瞻性研究设计进行癌症早期检测的生物标志物研究。
Biochim Biophys Acta. 2014 May;1844(5):874-83. doi: 10.1016/j.bbapap.2013.12.007. Epub 2013 Dec 17.
8
Novel approaches to identification of biomarkers for detection of early stage cancer.用于检测早期癌症的生物标志物识别新方法。
Dis Markers. 2002;18(2):73-81. doi: 10.1155/2002/589075.
9
Evaluating markers for the early detection of cancer: overview of study designs and methods.评估癌症早期检测标志物：研究设计与方法概述
Clin Trials. 2006;3(1):43-56. doi: 10.1191/1740774506cn130oa.
10
Molecular and biochemical methods in cancer epidemiology and prevention: the path between the laboratory and the population. AACR special conference in cancer research.癌症流行病学与预防中的分子和生化方法：实验室与人群之间的路径。美国癌症研究协会癌症研究特别会议
Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):85-8.
引用本文的文献
1
Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.肺癌的化学预防：肺癌的诊断和管理，第 3 版：美国胸科医师学会循证临床实践指南。
Chest. 2013 May;143(5 Suppl):e40S-e60S. doi: 10.1378/chest.12-2348.
2
Getting it right: being smarter about clinical trials.做对事情：更明智地开展临床试验。
PLoS Med. 2006 Apr;3(6):e144. doi: 10.1371/journal.pmed.0030144.
Zotero 插件